Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 0115-9941

8 FDA label images from Amneal Pharmaceuticals Of New York Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 0115-9941). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3 (Lamotrigine Orally Disintegrating Tablets Usp 1)

3 (Lamotrigine Orally Disintegrating Tablets Usp 1)
Chemical structure of lamotrigine, showing a chlorinated phenyl ring attached to a triazine ring with amine groups, characteristic of this anticonvulsant medication.*
FDA Label Image

1 (Lamotrigine Orally Disintegrating Tablets Usp 2)

1 (Lamotrigine Orally Disintegrating Tablets Usp 2)
A Kaplan-Meier failure probability plot comparing Lamotrigine and Placebo over approximately 100 weeks. The vertical axis shows failure probability percentage, and the horizontal axis shows time in weeks. The graph includes censored data points marked on both curves.*
FDA Label Image

2 (Lamotrigine Orally Disintegrating Tablets Usp 3)

2 (Lamotrigine Orally Disintegrating Tablets Usp 3)
A line graph showing failure probability (%) over weeks for Lamotrigine versus placebo. The x-axis represents time in weeks (0 to 80), and the y-axis shows failure probability from 0% to 100%. Two lines compare outcomes: one labeled Lamotrigine and the other Placebo. The chart includes censored data points indicated by small marks along the lines.*
FDA Label Image

12 (Lamotrigine Orally Disintegrating Tablets Usp 4)

12 (Lamotrigine Orally Disintegrating Tablets Usp 4)
This image displays descriptions of Lamotrigine orally disintegrating tablets in four strengths: 25 mg, 50 mg, 100 mg, and 200 mg. Each off-white to white circular tablet is debossed with a unique code (IX526, IX527, IX528, IX529) on one side and is plain on the other side.*
FDA Label Image

1 (Lamotrigine Orally Disintegrating Tablets Usp 5)

1 (Lamotrigine Orally Disintegrating Tablets Usp 5)
Label for Lamotrigine Orally Disintegrating Tablets, USP, 25 mg strength. The label shows a white round tablet marked with 'IX526'. The package contains 30 tablets and is distributed by Amneal Pharmaceuticals LLC. The label includes usage cautions, storage instructions, and manufacturer details, Amneal Pharmaceuticals Pvt. Ltd., India.*
FDA Label Image

3 (Lamotrigine Orally Disintegrating Tablets Usp 6)

3 (Lamotrigine Orally Disintegrating Tablets Usp 6)
Lamotrigine 50 mg orally disintegrating tablets label from Amneal Pharmaceuticals. The label shows dosage strength, tablet count of 30, NDC number 0115-9940-01, and includes storage instructions and warnings. The package displays the Amneal logo and provides manufacturer and distributor information, along with a barcode.*
FDA Label Image

5 (Lamotrigine Orally Disintegrating Tablets Usp 7)

5 (Lamotrigine Orally Disintegrating Tablets Usp 7)
Label for Lamotrigine 100 mg Orally Disintegrating Tablets, USP by Amneal Pharmaceuticals of New York LLC. The label shows a tablet imprint IX528 and a package size of 30 tablets. It includes dosage form, strength, caution statements for pharmacists and phenylketonurics, storage instructions, and manufacturer details from Amneal Pharmaceuticals Pvt. Ltd. The barcode and a designated area for lot and expiration dates are also visible.*
FDA Label Image

7 (Lamotrigine Orally Disintegrating Tablets Usp 8)

7 (Lamotrigine Orally Disintegrating Tablets Usp 8)
Lamotrigine 200 mg orally disintegrating tablets label from Amneal Pharmaceuticals of New York LLC. This prescription drug packaging shows 30 tablets per container. The label includes the NDC 0115-9942-01, storage instructions at 20 to 25°C, child-resistant packaging, and caution for phenylketonurics with 11.20 mg phenylalanine per tablet. Manufacturer is Amneal Pharmaceuticals Pvt. Ltd., India, distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.